On Feb. 26, Boston Scientific completed a $1 billion public offering of 4 percent interest rate senior notes due March 1, 2028.
Here's what you should know:
1. The proceeds of the offering will redeem the 2.65 percent notes that were due October 2016. Boston Scientific had approximately $600 million in aggregate principal outstanding on the notes as of Feb. 26.
2. The company needs to repay short-term debt and related fees, expenses and premiums.
3. Once paid, Boston Scientific will provide redemption notices to trustees.